| First Author | Yang L | Year | 2025 |
| Journal | Sci Adv | Volume | 11 |
| Issue | 13 | Pages | eadt4770 |
| PubMed ID | 40138419 | Mgi Jnum | J:364195 |
| Mgi Id | MGI:8167816 | Doi | 10.1126/sciadv.adt4770 |
| Citation | Yang L, et al. (2025) The expression order determines the pioneer functions of NGN3 and NEUROD1 in pancreatic endocrine differentiation. Sci Adv 11(13):eadt4770 |
| abstractText | Pioneer transcription factors (TFs) initiate chromatin remodeling, which is crucial for gene regulation and cell differentiation. In this study, we investigated how the sequential expression of neurogenin 3 (NGN3) and NEUROD1 affects their pioneering functions during pancreatic endocrine differentiation. Using a genetically engineered mouse model, we mapped NGN3-binding sites, confirming the pivotal role of this molecule in regulating chromatin accessibility. The pioneering function of NGN3 involves dose tolerance, and low doses are sufficient. Although NEUROD1 generally acts as a conventional TF, it can assume a pioneering role in the absence of NGN3. The sequential expression of NeuroD1 and Ngn3 predominantly drives alpha cell generation, which may explain the inefficient beta cell induction observed in vitro. Our findings demonstrate that pioneer activity is dynamically shaped by temporal TF expression and inter-TF interactions, providing insights into transcriptional regulation and its implications for disease mechanisms and therapeutic targeting and enhancing in vitro differentiation strategies. |
